Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT00697567
Eligibility Criteria:
Inclusion Criteria:
* Between 18 and 40 years of age
* Written informed consent
* Female volunteers must be using contraceptive and should avoid becoming pregnant for the duration of this study.
* Good clinical condition as evidenced by history taking and physical examination
Exclusion Criteria:
* History of persistent hepatic, renal, cardiac or respiratory diseases.
* Clinical signs of acute illness at the time of entry into the study.
* Seropositive for antibodies against the human immunodeficiency virus (HIV).
* Pregnancy, lactation.
* Treatment with corticosteroids or immunomodulating drugs.
* Simultaneous participation in another clinical trial.
* Any previous history of allergy.
* Any concomitant vaccination or administration of immunoglobulin during the study period.
* Any abnormal laboratory value among the tests performed at screening
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT00697567
Study Brief:
Protocol Section:
NCT00697567